Phathom Pharmaceuticals, Inc.
PHAT
$9.58
$0.404.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 76.81% | 67.80% | 71.59% | 64.98% | 17.10% |
| Total Depreciation and Amortization | -33.72% | -37.85% | -33.68% | -18.32% | -12.69% |
| Total Amortization of Deferred Charges | 24.25% | 21.26% | 28.62% | 31.58% | 46.80% |
| Total Other Non-Cash Items | -33.84% | -29.86% | -41.88% | -16.91% | -12.24% |
| Change in Net Operating Assets | 144.24% | 117.33% | 144.78% | -212.42% | -850.64% |
| Cash from Operations | 96.92% | 81.58% | 92.12% | 77.80% | 11.30% |
| Capital Expenditure | 54.64% | -238.89% | -1,640.00% | 38.64% | -110.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 54.64% | -238.89% | -1,640.00% | 38.64% | -110.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,338.75% | -- | -2.39% | -99.76% | 280.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,338.75% | -- | -100.37% | -100.22% | -99.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.51% | 159.96% | 86.14% | -124.66% | -36.42% |